Wealth Alliance’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,655
| Closed | -$249K | – | 546 |
|
|
2025
Q1 | $249K | Sell |
1,655
-67
| -4% | -$10.1K | 0.03% | 441 |
|
|
2024
Q4 | $318K | Sell |
1,722
-183
| -10% | -$33.8K | 0.04% | 368 |
|
|
2024
Q3 | $375K | Buy |
1,905
+37
| +2% | +$7.29K | 0.04% | 342 |
|
|
2024
Q2 | $386K | Buy |
1,868
+10
| +0.5% | +$2.07K | 0.05% | 313 |
|
|
2024
Q1 | $503K | Buy |
1,858
+6
| +0.3% | +$1.63K | 0.07% | 270 |
|
|
2023
Q4 | $438K | Sell |
1,852
-22
| -1% | -$5.2K | 0.06% | 283 |
|
|
2023
Q3 | $367K | Sell |
1,874
-49
| -3% | -$9.6K | 0.06% | 296 |
|
|
2023
Q2 | $404K | Buy |
1,923
+235
| +14% | +$49.4K | 0.06% | 292 |
|
|
2023
Q1 | $341K | Sell |
1,688
-82
| -5% | -$16.5K | 0.06% | 323 |
|
|
2022
Q4 | $386K | Buy |
1,770
+353
| +25% | +$76.9K | 0.07% | 282 |
|
|
2022
Q3 | $279K | Sell |
1,417
-252
| -15% | -$49.6K | 0.06% | 338 |
|
|
2022
Q2 | $358K | Buy |
1,669
+75
| +5% | +$16.1K | 0.07% | 280 |
|
|
2022
Q1 | $453K | Buy |
1,594
+29
| +2% | +$8.24K | 0.09% | 237 |
|
|
2021
Q4 | $590K | Sell |
1,565
-59
| -4% | -$22.2K | 0.12% | 195 |
|
|
2021
Q3 | $670K | Sell |
1,624
-24
| -1% | -$9.9K | 0.15% | 154 |
|
|
2021
Q2 | $610K | Buy |
1,648
+112
| +7% | +$41.5K | 0.14% | 167 |
|
|
2021
Q1 | $445K | Buy |
1,536
+85
| +6% | +$24.6K | 0.12% | 193 |
|
|
2020
Q4 | $363K | Sell |
1,451
-242
| -14% | -$60.5K | 0.11% | 233 |
|
|
2020
Q3 | $383K | Buy |
1,693
+30
| +2% | +$6.79K | 0.14% | 179 |
|
|
2020
Q2 | $290K | Buy |
+1,663
| New | +$290K | 0.11% | 227 |
|